Novavax
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Novavax 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About NVAX
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines.
CEOJohn C.s Jacobs
CEOJohn C.s Jacobs
Employees952
Employees952
HeadquartersGaithersburg, Maryland
HeadquartersGaithersburg, Maryland
Founded1987
Founded1987
Employees952
Employees952
NVAX Key Statistics
Market cap1.12B
Market cap1.12B
Price-Earnings ratio3.87
Price-Earnings ratio3.87
Dividend yield—
Dividend yield—
Average volume2.96M
Average volume2.96M
High today$6.87
High today$6.87
Low today$6.73
Low today$6.73
Open price$6.78
Open price$6.78
Volume2.09M
Volume2.09M
52 Week high$11.55
52 Week high$11.55
52 Week low$5.01
52 Week low$5.01
Stock Snapshot
With a market cap of 1.12B, Novavax(NVAX) trades at $6.84. The stock has a price-to-earnings ratio of 3.87.
During the trading session on 2025-12-04, Novavax(NVAX) shares reached a daily high of $6.87 and a low of $6.73. At a current price of $6.84, the stock is +1.6% higher than the low and still -0.4% under the high.
Trading volume for Novavax(NVAX) stock has reached 2.09M, versus its average volume of 2.96M.
The stock's 52-week range extends from a low of $5.01 to a high of $11.55.
The stock's 52-week range extends from a low of $5.01 to a high of $11.55.
Analyst ratings
50%
of 10 ratingsBuy
50%
Hold
20%
Sell
30%
People also own
Based on the portfolios of people who own NVAX. This list is generated using Robinhood data, and it’s not a recommendation.